Maxigesic IV Phase 3 Bunionectomy Study

PHASE3CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

October 26, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

September 15, 2017

Conditions
Post Operative Pain
Interventions
DRUG

Maxigesic IV

IV acetaminophen 1000 mg and IV ibuprofen 300 mg /100 mL solution for infusion, 100mL, every 6 hours for 48 hours

DRUG

IV Acetaminophen

IV Acetaminophen 1000 mg/100 mL solution for infusion, 100mL, every 6 hours for 48 hours

DRUG

IV Ibuprofen

IV Ibuprofen 300 mg/100 mL solution for infusion, 100mL, every 6 hours for 48 hours

DRUG

Placebo IV

Placebo IV- 100 mL intravenous saline for infusion, 100mL, every 6 hours for 48 hours

Trial Locations (2)

21122

Chesapeake Reserach Group, Pasadena

78705

Optimal Research, Austin

Sponsors
All Listed Sponsors
lead

AFT Pharmaceuticals, Ltd.

INDUSTRY